Perihal Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
Ibu pejabatCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Ditubuhkan2013
StatusAktif
Paten60 paten
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Log masuk untuk melihat semua 60 paten
Layari keseluruhan portfolio paten, dengan nombor penerbitan, tarikh dan keluarga.
Log masuk Cipta akaun dengan e-mel andaIa percuma
Dengan meneruskan, anda bersetuju dengan Perjanjian Pengguna, Dasar Privasi dan Dasar Kuki milik Heelky.
Ulasan
Belum ada ulasan. Pernah bekerja dengan Onyx Pharmaceuticals, Inc.? Jadilah yang pertama berkongsi pengalaman anda.
Maklumat undang-undang
| Nama sah | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Lihat di GLEIF ↗ |
| Alamat berdaftar | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Status | Aktif |
Sumber: GLEIF · dikemas kini 16 Okt 2026
Hubungan & pautan
Lokasi
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Adakah ini syarikat anda?
Tuntut halaman ini secara percuma untuk menambah logo, produk, foto dan kerja anda, serta menjawab ulasan.
Tuntut halaman iniSertai Heelky untuk berhubung, menggaji dan berkembang
Cipta akaun percuma untuk menghantar mesej, memohon kerja dan menyiarkan misi.
Sertai sekarang — percuma